Literature DB >> 4168693

Effects of beta-adrenergic blockade during exercise in hypertensive and ischaemic heart-disease.

E Shinebourne, J Fleming, J Hamer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 4168693     DOI： 10.1016/s0140-6736(67)90561-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  21 in total

1.  Cardiovascular response to exercise under increasing doses of chlorthalidone.

Authors:  R I Ogilvie
Journal:  Eur J Clin Pharmacol       Date:  1976-03-22       Impact factor: 2.953

2.  Problems with Beta Adrenergic Blocking Drugs and other Antihypertensive Drugs.

Authors:  B N Prichard
Journal:  Proc R Soc Med       Date:  1977

Review 3.  The second Lilly Prize Lecture, University of Newcastle, July 1977. beta-Adrenergic receptor blockade in hypertension, past, present and future.

Authors:  B N Prichard
Journal:  Br J Clin Pharmacol       Date:  1978-05       Impact factor: 4.335

4.  The kidney and antihypertensive therapy.

Authors:  R R Bailey
Journal:  Drugs       Date:  1976       Impact factor: 9.546

5.  Long term treatment of moderate hypertension with penbutolol (Hoe 893d). I. Effects on blood pressure, pulse rate, catecholamines in blood and urine, plasma renin activity and urinary aldosterone under basal conditions and following exercise.

Authors:  B G Hansson; B Hökfelt
Journal:  Eur J Clin Pharmacol       Date:  1975-10-10       Impact factor: 2.953

6.  Direct assessment of cardiac function.

Authors:  J Hamer
Journal:  Br J Clin Pharmacol       Date:  1978-07       Impact factor: 4.335

7.  Long term treatment of moderate hypertension with the beta1-receptor blocking agent metoprolol. II. Effect of submaximal work and insulin-induced hypoglycaemia on plasma catecholamines and renin activity, blood pressure and pulse rate.

Authors:  B G Hansson; J F Dymling; P Manhem; B Hökfelt
Journal:  Eur J Clin Pharmacol       Date:  1977-04-20       Impact factor: 2.953

8.  Cardiac work and contractility.

Authors:  J Hamer
Journal:  Br Heart J       Date:  1968-07

9.  Combination therapy of essential hypertension with pindolol (Visken) and hydralazine.

Authors:  I Persson
Journal:  Eur J Clin Pharmacol       Date:  1975-12-19       Impact factor: 2.953

10.  Hypotensive effect of oxprenolol in mild to moderate hypertension: a multicentre controlled study.

Authors:  M Motolese; G Muiesan; A Colombi
Journal:  Eur J Clin Pharmacol       Date:  1975       Impact factor: 2.953
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.